Právní předpis byl sestaven k datu 02.07.2026.
Zobrazené znění právního předpisu je účinné od 22.02.2023.
Sdělení Ministerstva zdravotnictví o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2023
41/2023 Sb.
41
SDĚLENÍ
Ministerstva xxxxxxxxxxxxx
xx dne 10. xxxxx 2023
x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx rok 2023
&xxxx;
Xxxxxxxxxxxx xxxxxxxxxxxxx podle §80 odst. 1 xxxx. x) xxxxxx x. 258/2000 Xx., x ochraně xxxxxxxxx xxxxxx x x xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, xx znění xxxxxxxxxx xxxxxxxx, xxxxxxx xx základě xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2023:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx
1x) kombinovaná xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx), virové xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xx xxxxxxxxxxxx 1 xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 xx méně xxx 30 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxx xxxxxxxxxx1 xx xxxx xxx 40 mezinárodních xxxxxxxx (XX)
Xxxxxxxx Xxxxxxxxxx pertussis:
Pertussis xxxxxxxxxx (XX)1 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX)1 25 xxxxxxxxxx Xxxxxxxxxxx (PRN)1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx hepatitidis X (HBs)2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx inactivatum (XXX)
xxxxx 1 (xxxx Xxxxxxx)4 40 D xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx MEF-1)4 8 X xxxxxxxx antigenu
typus 3 (kmen Xxxxxxx)4 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx influenzae xxxxx x xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 10 mikrogramů
conj. xxx xxxxxx. xxxxxxxx jako xxxxx xxxxxxx přibližně 25 xxxxxxxxxx
1 adsorbováno xx xxxxxxxx xxxxxxx, xxxxxxxxxxx (Xx(XX)3) 0,5 xxxxxxxxx Xx3+
2 xxxxxxxx xxxxxxxxxxxxx XXX xxxxxxxxxxx xx xxxxxxx xxxxxxxxxxxx xxxxx Xxxxxxxxxxxxx xxxxxxxxxx)
3 xxxxxxxxxxx na xxxxxxxxxxx xxxxxxx (XxXX4) 0,32 xxxxxxxxx Xx3+
4 pomnoženo xx VERO xxxxxxx
XXXX
1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (acelulární xxxxx), xxxxxx, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx hepatitidě X, xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xxxxx xxxxx1 (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx xx xxxx xxx 20 xxxxxxxxxxxxx jednotek (XX)2
Xxxxxx anatoxinum xx xxxx xxx 40 xxxxxxxxxxxxx jednotek (XX)2
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx xxxxxxxxxx 25 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx 25 mikrogramů
Virus Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3
xxxxx 1 (Xxxxxxx) 40 X xxxxxxxx xxxxxxxx4
xxxxx 2 (XXX-1) 8 D jednotek xxxxxxxx4
xxxxx 3 (Saukett) 32 X xxxxxxxx xxxxxxxx4
Xxxxxxxxx tegiminis xxxxxxxxxxx X5 10 mikrogramů
Polyribosylribitoli xxxxxxxx xxxxxxxxxx xxxxxxxxxx X 12 xxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)
xxxxxxxxx xxx xxxxxx xxxxxxxxxx 22-36 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx xxxxxxx (0,6 xx Xx3+)
2 xxxx xxxxxx mez spolehlivosti (x = 0,95)
3 xxxxxxxxx na XXXX xxxxxxx
4 xxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx
5 xxxxxxxx xxxxxxxxxxxxx XXX xxxxxxxxxxx x xxxxxxxxxxxx xxxxxxx Xxxxxxxxx polymorpha
NEBO
1ab) Xxxxxxx xxxxx xxxxxxx, xxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx komponenta), hepatitidě X (xXXX), dětské xxxxxxxx xxxxx (xxxxxxxxxxxx) x xxxxxxxxxxx xxxxxxx xxxxx Haemophilus xxxx x (xxxxxxxxxxx)
Xxxxx xxxxx (0,5 ml) obsahuje:
Diphtheriae xxxxxxxxxx1 xx xxxx xxx 20 XX
Xxxxxx xxxxxxxxxx1 ne méně xxx 40 XX
Xxxxxxxx Xxxxxxxxxxx xxxxxxxx1
Xxxxxxxxx anatoxinum (XX) 20 xxxxxxxxxx
Xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 20 xxxxxxxxxx
Xxxxxxxxxxx (PRN) 3 xxxxxxxxxx
Xxxxxxxx xxxx 2 xx 3 (XXX) 5 mikrogramů
Antigenum xxxxxxxxx xxxxxxxxxxx X2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx (xxxxxxxxxxx)4
Xxxxx 1 (Xxxxxxx) 40 X jednotek antigenu5
Typus 2 (XXX-1) 8 X jednotek xxxxxxxx5
Xxxxx 3 (Xxxxxxx) 32 X xxxxxxxx xxxxxxxx5
Xxxxxxxxxxxxxx Xxxxxxxxxx xxxxxxxxxx xxxxx x
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 3 xxxxxxxxxx xxxxxxxxxx cum xxxxxxxxx xxxxxxxxxxxx typus x2 50 mikrogramů
1 xxxxxxxxxxx na fosforečnan xxxxxxx (0,17 xx Xx3+)
2 adsorbováno xx xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxx (0,15 xx Xx3+)
3 xxxxxxxx xxxxxxxxxxxxx XXX xxxxxxxxxxx x xxxxxxxxxxxx buňkách Saccharomyces xxxxxxxxxx
4 pomnoženo xx Xxxx xxxxxxx
5 nebo xxxxxxxxxxxx xxxxxxxx antigenu xxxxxxxxx vhodnou imunochemickou xxxxxxx.
1x) xxxxxxxx látka xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx (DTaP)
Jedna dávka (0,5 xx) xxxxxxxx xxxx léčivé xxxxx:
Xxxxxxxxxxx xxxxxxxxxx* ≥ 30 XX
Xxxxxx anatoxinum* ≥ 40 XX
Xxxxxxxxx anatoxinum* (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx filamentosum* (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx* (69 xX) 8 mikrogramů
* xxxxxxxxxxx xx hydroxid xxxxxxx xxxxxx: 0,5 xxxxxxxxx
XXXX
1xx) Xxxxxxxx látka xxxxx záškrtu, xxxxxx x dávivému xxxxx (xxxxxxxxxx) xx sníženým xxxxxxx antigenů (Xxxx)
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx - Xxxxxxxxx 2 IU* (2 Xx)
Xxxxxx xxxxxxxxxx - Minimálně 20 XX* (5 Lf)
Pertusové xxxxxxxx
Xxxxxxxxx xxxxxxxxxx - 2,5 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx - 5 xxxxxxxxxx
Xxxxxxxxxxx - 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 xx 3 - 5 xxxxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx - 1,5 xx (0,33 xx xxxxxxx)
* Xxxx spodní xxxxxxx xxxxxxxxx xxxxxxxxxxxxx (x = 0,95) xxxxxxxx xxxxxx xxxxx xxxxx xxxxxxxxx x Xxxxxxxxx lékopisu.
NEBO
1bb) Očkovací xxxxx xxxxx záškrtu, xxxxxx a xxxxxxxx xxxxx (xxxxxxxxxx xxxxxxxxxx) xx xxxxxxxx obsahem xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 2 mezinárodní xxxxxxxx (XX) (2,5 Xx)
Xxxxxx anatoxinum1 xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (IU) (5 Lf)
Bordetellae xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx membranae xxxxxxxx xxxxxxxxx1 2,5 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx hydroxid xxxxxxx (Xx(XX)3) 0,3 xxxxxxxxx Xx3+ a xxxxxxxxxxx xxxxxxx (XxXX4) 0,2 xxxxxxxxx Xx3+
1x) očkovací xxxxx proti nákazám xxxxxxxxx Haemophilus xxxxxxxxxx xxx x:
Xxxxx dávka xxxxxxxxxxxxx vakcíny xxxxxxxx:
Xxxxxxxxxxxxxxx Xxx purificatum (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).
1x) xxxxxxxx xxxxx xxxxx tetanu:
Jedna dávka xxxxxxxx:
Xxxxxx xxxxxxxxxx - xxx. 40 mezinárodních xxxxxxxx
1x) očkovací látka xxxxx virové hepatitidě X x xxxxxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 10 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X x dospělé formuli
Jedna xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 20 mikrogramů
1g) očkovací xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Schwarz) min. 103,0 xxxxxxxx xxxxx xxx buněčnou kulturu503
Parotitidis xxxxx xxxxxxxxxx1 (RIT 4385) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Wistar XX 27/3) min. 103,0 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx503
1 pomnoženo xx buňkách kuřecích xxxxxx
2 pomnoženo na xxxxxxxx diploidních xxxxxxx (XXX-5)
3 50% xxxxxxxx xxxxx tkáňové xxxxxxx
XXXX
1xx) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, příušnicím a xxxxxxxxx
Xx xxxxxxxxxx obsahuje xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (kmen Xxxxxx’ Xxxxxxxxx) ne xxxx xxx 1x103 CCID50*
Virus xxxxxxxxxxx1 vivum attenuatum (xxxx Xxxxx Lynn™, xxxxxxx X) xx xxxx xxx 12,5x103 XXXX50*
Xxxxx xxxxxxxx2 xxxxx xxxxxxxxxx (kmen Xxxxxx XX 27/3) xx xxxx xxx 1x103 XXXX50*
* 50 % xxxxxxxx xxxxx xxxxxxx xxxxxxx
1 vyrobeno xx xxxxxxx xxxxxxxx xxxxxx.
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxxx WI-38 xxxxxxxxxxxxx.
1x) xxxxxxxx látka xxxxx xxxxxx přenosné xxxxx v xxxxxxxxxxxx xxxxx:
Xxxxx xxxxx obsahuje:
Virus xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Mahoney).....40 antigenních X jednotek*
Virus poliomyelitis xxxxxxxxxxx xxxxx 2 (XXX-1) ..........8 antigenních X jednotek*
Virus poliomyelitis xxxxxxxxxxx xxxxx 3 (Xxxxxxx)........32 xxxxxxxxxxx D xxxxxxxx*
* xxxx množství xxxxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxx vhodné imunochemické xxxxxx.
1xx) xxxxxxxx xxxxx xxxxx pneumokokovým xxxxxxxx xxxxxxxxx v xxxxxxxxxx xxxxxxxx:
1xxx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 11 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 31 2,2 µg
Streptococci pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 41 2,2 µg
Streptococci pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 51 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 6A1 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx sérotypus 6X1 4,4 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx sérotypus 7X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9V1 2,2 µg
Streptococci pneumoniae xxxxxxxxxxxxxxx sérotypus 141 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 18X1 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 19A1 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23F1 2,2 µx
1 Konjugován x nosným xxxxxxxxx XXX197 a xxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (0,125 xx xxxxxxx).
1xxx) xxxxxxxxxxxxxxx očkovací látka xxxxxxxx:
xx 25 xxxxxxxxxxxx xxxxxxxxxxxxx 23 pneumokokových xxxxxxxxxxxxxxxxx sérotypů: 1, 2, 3, 4, 5, 6X, 7X, 8, 9N, 9X, 10X, 11X, 12X, 14, 15X, 17F, 18X, 19F, 19X, 20, 22X, 23F, 33X.
1x) očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 - xx xxxx než 2 xxxxxxxxxxx jednotky (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 - ne xxxx xxx 20 xxxxxxxxxxxxx jednotek (XX) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 - 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 - 8 xxxxxxxxxx
Xxxxxxxxx1 2,5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
xxxxx 1 (xxxx Xxxxxxx)2 - 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (kmen XXX-1)2 - 8 X jednotek antigenu
typus 3 (xxxx Xxxxxxx)2 - 32 X xxxxxxxx antigenu
1 Xxxxxxxxxxx xx hydratovaný hydroxid xxxxxxx (Xx(XX)3) 0,3 xxxxxxxxx Xx3+ a xxxxxxxxxxx hlinitý (XxXX4) 0,2 miligramu Xx3+
2 xxxxxxxxx na XXXX xxxxxxx
XXXX
1xx) očkovací xxxxx xxxxx xxxxxxx, dávivému xxxxx (acelulární xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx minimálně 2 IU* (2,5 Xx)
Xxxxxx xxxxxxxxxx xxxxxxxxx 20 XX* (5 Xx)
Xxxxxxxxx antigeny:
Pertussis xxxxxxxxxx 2,5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx 5 xxxxxxxxxx
Xxxxxxxxxxx 3 mikrogramy
Fimbriae, typi 2 xx 3 5 mikrogramů
Virus xxxxxxxxxxxxxxx (xxxxxxxxxxx)**
xxxxx 1 40 X jednotek xxxxxxxx
xxxxx 2 8 X xxxxxxxx xxxxxxxx
xxxxx 3 32 X jednotek xxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx 1,5 mg (0,33 mg xxxxxxx)
* Xxxx xxxxxx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx (p = 0,95) xxxxxxxx xxxxxx podle xxxxx xxxxxxxxx x Xxxxxxxxx xxxxxxxx.
** Kultivováno xx Xxxx xxxxxxx.
1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxxx (XXX vakcína)
1k) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X xxx xxxxx xxxxxxxx do xxxxxxxxxxxx programu:
Jedna xxxxx (0,5 ml) xxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X1,2,3 - 20 xxxxxxxxxx
1 adjuvovaný xx XX04X xxxxxxxxxx: - 3-0-xxxxxx-4'-xxxxxxxxxxxx-xxxxx X (XXX)2 50 xxxxxxxxxx
2 xxxxxxxxxxx xx xxxxxxxxxxx hlinitý (xxxxxx 0,5 xxxxxxxxx Xx3+)
3 xxxxxxxx xx xxxxxxx xxxxxxxxxxxx xxxxx (Xxxxxxxxxxxxx xxxxxxxxxx) rekombinantní XXX xxxxxxxxxxx.
2. Antigenní xxxxxxx očkovacích xxxxx xxx zvláštní očkování
2a) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx B xx formuli xxx xxxxxxx:
Xxxxx dávka obsahuje:
Antigenum xxxxxxxxx xxxxxxxxxxx X - 20 mikrogramů
2b) xxxxxxxx látka xxxxx xxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx A xxxxx xxxxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, příušnicím x zarděnkám:
Jedna dávka xxxxxxxx:
Xxxxxxxxxxx xxxxx attenuatum1 (Xxxxxxx) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx virus xxxxxxxxxx1 (XXX 4385) xxx. 103,7 infekční xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx na xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxxx xx lidských xxxxxxxxxxx xxxxxxx (MRC-5)
3 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
2xx) xxxxxxxx xxxxx proti spalničkám, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx obsahuje xxxxx xxxxx (0,5 ml):
Virus xxxxxxxxxxx1 xxxxx attenuatum (xxxx Xxxxxx’ Xxxxxxxxx) xx xxxx než 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 xxxxx attenuatum (xxxx Xxxxx Lynn™, hladina X) xx méně xxx 12,5x103 XXXX50*
Xxxxx xxxxxxxx2 vivum xxxxxxxxxx (xxxx Xxxxxx XX 27/3) ne méně xxx 1x103 XXXX50*
* 50 % infekční xxxxx buněčné xxxxxxx
1 xxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx.
2 xxxxxxxx xx xxxxxxxx diploidních xxxxxxxx XX-38 xxxxxxxxxxxxx.
3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxx xxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Xxxxx xxxxxxxxx X xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx A ve xxxxxxx pro xxxx:
Xxxxx xxxxxxxxx X xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
Xxxxx xxxxx obsahuje:
Morbillorum xxxxx attenuatum1 (Schwarz) xxx. 103,0 xxxxxxxx xxxxx xxx buněčnou xxxxxxx503
Xxxxxxxxxxx virus xxxxxxxxxx1 (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx attenuatum2 (Wistar XX 27/3) xxx. 103,0 infekční xxxxx xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx na buňkách xxxxxxxx xxxxxx
2 xxxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxx (MRC-5)
3 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
3xx) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 ml):
Virus morbillorum1 xxxxx attenuatum (kmen Xxxxxx’ Edmonston) xx xxxx xxx 1x103 XXXX50*
Xxxxx parotitidis1 xxxxx xxxxxxxxxx (kmen Xxxxx Xxxx™, hladina X) xx xxxx xxx 12,5x103 XXXX503
Xxxxx rubeolae2 xxxxx xxxxxxxxxx (xxxx Xxxxxx XX 27/3) xx xxxx xxx 1x1103 CCID503
* 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
1 vyrobeno xx xxxxxxx xxxxxxxx xxxxxx.
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxxx XX-38 xxxxxxxxxxxxx.
&xxxx;
Xxxxxxx:
xxxx. XXXx. Válek, XXx., MBA, EBIR, x. x.
Xxxxxxxxx
Xxxxxx xxxxxxx x. 41/2023 Sb. xxxxx xxxxxxxxx dnem 22.2.2023.
Ke xxx xxxxxxxx právní xxxxxxx nebyl xxxxx xx doplňován.
Znění xxxxxxxxxxxx xxxxxxxx norem jiných xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx se xxxx xxxxxx xxxxxxxxx změna xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.